长风药业股份有限公司（02652）于2026年5月8日回购股份11,500股，占当日公司已发行股本（不含库存股份）约0.0038%。此次回购价格区间介乎每股21.58港元至21.9港元，合计耗资250,070港元，折合约25.01万港元。
本次回购完成后，公司已发行股本（不含库存股份）由2026年5月7日的301,536,086股变更为301,524,586股，库存股份数量由687,500股增至699,000股，总股本维持在302,223,586股。
据公告显示，上述回购基于2025年12月16日通过的购回授权，该授权可回购股份总数为30,222,358股。公司确认，本次回购已遵守《香港联合交易所有限公司证券上市规则》及相关法律法规的要求。
公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.